Diffuse coronary disease and atherothrombosis: A rationale for long-term therapy to prevent recurrent ischemic events

Journal of Invasive Cardiology

Volumn 15, Issue SUPPL. B, 2003, Pages

  Bhatt, Deepak L ^a   Cannon, Chris ^b   King, Spencer ^b   Rapaport, Elliot ^b   Dullum, Mercedes ^b   Driesman, Mitch ^b   Waksman, Ron ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Dept of Cardiovascular Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; CD40 LIGAND; CLOPIDOGREL;

ANGIOGRAPHY; ANGIOSCOPY; ARTERY OCCLUSION; ARTERY THROMBOSIS; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTRON BEAM TOMOGRAPHY; HEART INFARCTION; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RESTENOSIS; RISK ASSESSMENT; SPECTROSCOPY; ST SEGMENT ELEVATION; THERMOGRAPHY; THROMBOCYTE ACTIVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; FEMALE; HUMANS; LONG-TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037345588     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Falk E, Shah PK, Fuster V, et al. Coronary plaque disruption. Circulation 1995;92:657-671.
2. Kerensky RA, Wade M, Deedwania P, et al. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 2002;39:1456-1463.
3. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-922.
4. Ridker PM. Role of hs-CRP in cardiovascular risk prediction. Am J Manag Care 2002 Jul; Suppl Symposium Reporter: 6,8
5. Rioufol G. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002;106:804-808.
6. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001;375:1284-1288.
7. Ault KA, Cannon CP, Mitchell J, et al. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1999;33:634-639.
8. Trip MD, Cats VM, van Capelle FJ, et al. Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction. N Engl J Med 1990;322:1549-1554.
9. Libby P, Simon DI. Inflammation and thrombosis: The clot thickens. Circulation 2001;103:1718-1720.
10. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: The switch-hitting player of cardiovascular disease. Circulation 2002;106:896-899.
11. Hermann A, Rauch BH, Braun M, et al. Platelet CD40 ligand (CD40L) - Subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001;12:74-82.
12. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation 1999;99:1965-1971.
13. Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of an elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001;104:992-997.
14. Chew DP, Bhatt DL, Robbins MA, et al. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol 2001;88:672-674.
15. Bhatt DL, Chew DP, Robbins MA, et al. Elevated baseline CRP levels predict death or MI in diabetic patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2001;37:66A.
16. Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation 2002;105:2000-2004.
17. Coccheri S, et al. Distribution and Overlap of Atherosclerosis in CAPRIE. Eur Heart J 1998;19(Suppl):P1268.
18. Bhatt D, Chew DP, Hirsch AT, et al. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001;103:363-368.
19. Bhatt D, Marso S, Hirsch A, et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002;90:625-628.